Myosin light chain kinase mediates intestinal barrier dysfunction via occludin endocytosis during anoxia/reoxygenation injury

American Journal of Physiology - Cell Physiology

Volumn 311, Issue 6, 2016, Pages C996-C1004

  Jin, Younggeon ^a   Blikslager, Anthony T ^a  

^a NORTH CAROLINA STATE UNIVERSITY   (United States)

Author keywords

Caco 2BBe1; Intestinal anoxia reoxygenation injury; Intestinal barrier functions; Myosin light chain kinase; Tight junctions

Indexed keywords

1 (5 IODO 1 NAPHTHALENESULFONYL)HEXAHYDRO 1H 1,4 DIAZEPINE; FLUORESCEIN ISOTHIOCYANATE DEXTRAN; MYOSIN LIGHT CHAIN KINASE; OCCLUDIN; TIGHT JUNCTION PROTEIN; DEXTRAN; MYOSIN LIGHT CHAIN;

ANOXIA; ARTICLE; CACO-2 CELL LINE; CONTROLLED STUDY; CYTOPLASM VESICLE; ELECTRIC RESISTANCE; ENDOCYTOSIS; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; EX VIVO STUDY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE MICROSCOPY; INTESTINE ISCHEMIA; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY MECHANISM; REOXYGENATION; REPERFUSION INJURY; TIGHT JUNCTION; WESTERN BLOTTING; ANIMAL; EPITHELIUM CELL; HYPOXIA; INTESTINE MUCOSA; METABOLISM; PATHOPHYSIOLOGY; PERMEABILITY; PHOSPHORYLATION; PHYSIOLOGY; PIG; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

ANIMALS; CACO-2 CELLS; CELL LINE, TUMOR; DEXTRANS; ENDOCYTOSIS; EPITHELIAL CELLS; HUMANS; HYPOXIA; INTESTINAL MUCOSA; MYOSIN LIGHT CHAINS; MYOSIN-LIGHT-CHAIN KINASE; OCCLUDIN; PERMEABILITY; PHOSPHORYLATION; SIGNAL TRANSDUCTION; SWINE; TIGHT JUNCTIONS;

EID: 85006275662     PISSN: 03636143     EISSN: 15221563     Source Type: Journal    
DOI: 10.1152/ajpcell.00113.2016     Document Type: Article

References (46)

1. Blikslager AT, Moeser AJ, Gookin JL, Jones SL, Odle J. Restoration of barrier function in injured intestinal mucosa. Physiol Rev 87: 545–564, 2007.
2. Camilleri M, Madsen K, Spiller R, Greenwood-Van Meerveld B, Verne GN. Intestinal barrier function in health and gastrointestinal disease. Neurogastroenterol Motil 24: 503–512, 2012.
3. Cerqueira NF, Hussni CA, Yoshida WB. Pathophysiology of mesenteric ischemia/reperfusion: a review. Acta Cir Bras 20: 336–343, 2005.
4. Clayburgh DR, Barrett TA, Tang Y, Meddings JB, Van Eldik LJ, Watterson DM, Clarke LL, Mrsny RJ, Turner JR. Epithelial myosin light chain kinase-dependent barrier dysfunction mediates T cell activation- induced diarrhea in vivo. J Clin Invest 115: 2702–2715, 2005.
5. Colgan SP, Taylor CT. Hypoxia: an alarm signal during intestinal inflammation. Nat Rev Gastroenterol Hepatol 7: 281–287, 2010.
6. Dahan S, Dalmasso G, Imbert V, Peyron JF, Rampal P, Czerucka D. Saccharomyces boulardii interferes with enterohemorrhagic Escherichia coli-induced signaling pathways in T84 cells. Infect Immun 71: 766–773, 2003.
7. Ebnet K. Organization of multiprotein complexes at cell-cell junctions. Histochem Cell Biol 130: 1–20, 2008.
8. Furuta GT, Turner JR, Taylor CT, Hershberg RM, Comerford K, Narravula S, Podolsky DK, Colgan SP. Hypoxia-inducible factor 1-dependent induction of intestinal trefoil factor protects barrier function during hypoxia. J Exp Med 193: 1027–1034, 2001.
9. Glover LE, Lee JS, Colgan SP. Oxygen metabolism and barrier regulation in the intestinal mucosa. J Clin Invest 26: 3680–3688, 2016.
10. Gonzalez LM, Moeser AJ, Blikslager AT. Animal models of ischemiareperfusion- induced intestinal injury: progress and promise for translational research. Am J Physiol Gastrointest Liver Physiol 308: G63–G75, 2015.
11. Hassoun HT, Kone BC, Mercer DW, Moody FG, Weisbrodt NW, Moore FA. Post-injury multiple organ failure: the role of the gut. Shock 15: 1–10, 2001.
12. Hu Q, Ziegelstein RC. Hypoxia/reoxygenation stimulates intracellular calcium oscillations in human aortic endothelial cells. Circulation 102: 2541–2547, 2000.
13. Ivanov AI, Hunt D, Utech M, Nusrat A, Parkos CA. Differential roles for actin polymerization and a myosin II motor in assembly of the epithelial apical junctional complex. Mol Biol cell 16: 2636–2650, 2005.
14. Kojima T, Murata M, Yamamoto T, Lan M, Imamura M, Son S, Takano K, Yamaguchi H, Ito T, Tanaka S, Chiba H, Hirata K, Sawada N. Tight junction proteins and signal transduction pathways in hepatocytes. Histol Histopathol 24: 1463–1472, 2009.
15. Kompan L, Kompan D. Importance of increased intestinal permeability after multiple injuries. Eur J Surg 167: 570–574, 2001.
16. Li Q, Zhang Q, Wang C, Liu X, Qu L, Gu L, Li N, Li J. Altered distribution of tight junction proteins after intestinal ischaemia/reperfusion injury in rats. J Cell Mol Med 13: 4061–4076, 2009.
17. Li Q, Zhang Q, Zhang M, Wang C, Zhu Z, Li N, Li J. Effect of n-3 polyunsaturated fatty acids on membrane microdomain localization of tight junction proteins in experimental colitis. FEBS J 275: 411–420, 2008.
18. Little D, Dean RA, Young KM, McKane SA, Martin LD, Jones SL, Blikslager AT. PI3K signaling is required for prostaglandin-induced mucosal recovery in ischemia-injured porcine ileum. Am J Physiol Gastrointest Liver Physiol 284: G46–G56, 2003.
19. Lukas TJ, Mirzoeva S, Slomczynska U, Watterson DM. Identification of novel classes of protein kinase inhibitors using combinatorial peptide chemistry based on functional genomics knowledge. J Med Chem 42: 910–919, 1999.
20. Ma TY, Boivin MA, Ye D, Pedram A, Said HM. Mechanism of TNF-α modulation of Caco-2 intestinal epithelial tight junction barrier: role of myosin light-chain kinase protein expression. Am J Physiol Gastrointest Liver Physiol 288: G422–G430, 2005.
21. Marchiando AM, Shen L, Graham WV, Weber CR, Schwarz BT, Austin JR, II Raleigh DR, Guan Y, Watson AJ, Montrose MH, Turner JR. Caveolin-1-dependent occludin endocytosis is required for TNF-induced tight junction regulation in vivo. J Cell Biol 189: 111–126, 2010.
22. Marin ML, Geller SA, Greenstein AJ, Marin RH, Gordon RE, Aufses AH Jr.. Ultrastructural pathology of Crohn’s disease: correlated transmission electron microscopy, scanning electron microscopy, and freeze fracture studies. Am J Gastroenterol 78: 355–364, 1983.
23. Moeser AJ, Haskell MM, Shifflett DE, Little D, Schultz BD, Blikslager AT. ClC-2 chloride secretion mediates prostaglandin-induced recovery of barrier function in ischemia-injured porcine ileum. Gastroenterology 127: 802–815, 2004.
24. Moeser AJ, Nighot PK, Engelke KJ, Ueno R, Blikslager AT. Recovery of mucosal barrier function in ischemic porcine ileum and colon is stimulated by a novel agonist of the ClC-2 chloride channel, lubiprostone. Am J Physiol Gastrointest Liver Physiol 292: G647–G656, 2007.
25. Nighot M, Moeser A, Ueno R, Blikslager A. Gastro protective properties of the novel prostone SPI-8811 against acid-injured porcine mucosa. World J Gastroenterol 18: 4684–4692, 2012.
26. Nighot PK, Blikslager AT. Chloride channel ClC-2 modulates tight junction barrier function via intracellular trafficking of occludin. Am J Physiol Cell Physiol 302: C178–C187, 2012.
27. Nighot PK, Moeser AJ, Ryan KA, Ghashghaei T, Blikslager AT. ClC-2 is required for rapid restoration of epithelial tight junctions in ischemic-injured murine jejunum. Exp Cell Res 315: 110–118, 2009.
28. Owens SE, Graham WV, Siccardi D, Turner JR, Mrsny RJ. A strategy to identify stable membrane-permeant peptide inhibitors of myosin light chain kinase. Pharm Res 22: 703–709, 2005.
29. Philpott DJ, McKay DM, Mak W, Perdue MH, Sherman PM. Signal transduction pathways involved in enterohemorrhagic Escherichia coliinduced alterations in T84 epithelial permeability. Infect Immun 66: 1680–1687, 1998.
30. Pierro A, Eaton S. Intestinal ischemia reperfusion injury and multisystem organ failure. Semin Pediatr Surg 13: 11–17, 2004.
31. Samak G, Gangwar R, Crosby LM, Desai LP, Wilhelm K, Waters CM, Rao R. Cyclic stretch disrupts apical junctional complexes in Caco-2 cell monolayers by a JNK-2-, c-Src-, and MLCK-dependent mechanism. Am J Physiol Gastrointest Liver Physiol 306: G947–G958, 2014.
32. Schmitz H, Barmeyer C, Fromm M, Runkel N, Foss HD, Bentzel CJ, Riecken EO, Schulzke JD. Altered tight junction structure contributes to the impaired epithelial barrier function in ulcerative colitis. Gastroenterology 116: 301–309, 1999.
33. Schwarz BT, Wang F, Shen L, Clayburgh DR, Su L, Wang Y, Fu YX, Turner JR. LIGHT signals directly to intestinal epithelia to cause barrier dysfunction via cytoskeletal and endocytic mechanisms. Gastroenterology 132: 2383–2394, 2007.
34. Scott KG, Meddings JB, Kirk DR, Lees-Miller SP, Buret AG. Intestinal infection with Giardia spp. reduces epithelial barrier function in a myosin light chain kinase-dependent fashion. Gastroenterology 123: 1179–1190, 2002.
35. Shen L, Black ED, Witkowski ED, Lencer WI, Guerriero V, Schneeberger EE, Turner JR. Myosin light chain phosphorylation regulates barrier function by remodeling tight junction structure. J Cell Sci 119: 2095–2106, 2006.
36. Shen L, Weber CR, Raleigh DR, Yu D, Turner JR. Tight junction pore and leak pathways: a dynamic duo. Ann Rev Physiol 73: 283–309, 2011.
37. Shin K, Fogg VC, Margolis B. Tight junctions and cell polarity. Ann Rev Cell Dev Biol 22: 207–235, 2006.
38. Su L, Nalle SC, Shen L, Turner ES, Singh G, Breskin LA, Khramtsova EA, Khramtsova G, Tsai PY, Fu YX, Abraham C, Turner JR. TNFR2 activates MLCK-dependent tight junction dysregulation to cause apoptosis-mediated barrier loss and experimental colitis. Gastroenterology 145: 407–415, 2013.
39. Taylor CT, Colgan SP. Hypoxia and gastrointestinal disease. J Mol Med 85: 1295–1300, 2007.
40. Turner JR. Intestinal mucosal barrier function in health and disease. Nat Rev Immunol 9: 799–809, 2009.
41. Turner JR, Rill BK, Carlson SL, Carnes D, Kerner R, Mrsny RJ, Madara JL. Physiological regulation of epithelial tight junctions is associated with myosin light-chain phosphorylation. Am J Physiol Cell Physiol 273: C1378–C1385, 1997.
42. Wang F, Graham WV, Wang Y, Witkowski ED, Schwarz BT, Turner JR. Interferon-γ and tumor necrosis factor-α synergize to induce intestinal epithelial barrier dysfunction by up-regulating myosin light chain kinase expression. Am J Pathol 166: 409–419, 2005.
43. Wang F, Schwarz BT, Graham WV, Wang Y, Su L, Clayburgh DR, Abraham C, Turner JR. IFN- -induced TNFR2 expression is required for TNF-dependent intestinal epithelial barrier dysfunction. Gastroenterology 131: 1153–1163, 2006.
44. Weber CR. Dynamic properties of the tight junction barrier. Ann N Y Acad Sci 1257: 77–84, 2012.
45. Yuan SY, Rigor RR. Regulation of Endothelial Barrier Function. San Rafael, CA: Morgan & Claypool Life Sciences, 2010.
46. Zolotarevsky Y, Hecht G, Koutsouris A, Gonzalez DE, Quan C, Tom J, Mrsny RJ, Turner JR. A membrane-permeant peptide that inhibits MLC kinase restores barrier function in in vitro models of intestinal disease. Gastroenterology 123: 163–172, 2002.